Rocket Pharmaceuticals Inc (RCKT)
R&D Expense Growth
-6.22%
Quarterly · Period ending:
RCKT R&D Expense Growth
Latest reported-6.22%period ending
Latest reported-6.22%period ending
RCKT Quarterly R&D Growth (QoQ) (0.00% → -6.22%)
Latest values, visible window
High-resolution chart · PNG
RCKT r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -6.2218% | |
| 7.1796% | |
| -13.8576% | |
| -20.1369% | |
| 18.6857% | |
| -3.7878% | |
| -11.7169% | |
| -5.53% | |
| 2.3583% | |
| 4.8294% | |
| -10.8872% | |
| -8.8337% | |
| 10.8085% | |
| -7.3266% | |
| 15.3378% | |
| 4.9013% | |
| 34.2989% | |
| -4.2505% | |
| -18.8284% | |
| 61.5206% | |
| -13.3491% | |
| -44.5324% | |
| 135.6605% | |
| 29.4424% | |
| -1.3328% | |
| 15.6054% | |
| -1.0857% | |
| 6.0047% | |
| -7.5841% | |
| -36.0769% | |
| 81.2476% | |
| 21.2867% | |
| 87.5675% | |
| 778.1346% | |
| -76.7921% | |
| -22.2406% | |
| -48.9362% | |
| -25.2397% | |
| 12.8507% | |
| 30.116% | |
| -15.1018% | |
| 28.6535% | |
| 63.8704% | |
| 84.8516% | |
| 82.7877% | |
| 14.0875% | |
| -24.6179% | |
| -33.2438% | |
| 20.129% | |
| -2.6382% | |
| 0% |